Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending July 19, 2020 Oral relugolix vs leuprolide in advanced prostate cancer, Enzalutamide improves survival in nonmetastatic castration-resistant prostate cancer, Hematological markers of prostate cancer risk, Localized prostate cancer: Radiotherapy without ADT shows no overall survival benefit, Men with IBD at higher risk of prostate cancer, More must reads Must reads for theWeek ending June 21, 2020 Prostate cancer: High luteinizing hormone levels correlate with unfavorable pathology, High DHT levels tied to lower risk of prostate cancer mortality, Metastatic CRPC: No survival benefit with enzalutamide plus atezolizumab, ADT for prostate cancer may provide partial protection against SARS-CoV-2, CRPC: Olaparib improves PFS after progression on hormone therapy, More must readsMust reads for theWeek ending June 14, 2020 Metastatic CRPC: No racial disparities in clinical trial outcomes, Prostate cancer: Guidelines for radiotherapy during the COVID-19 pandemic, Nonsteroidal antiandrogens improve survival in nonmetastatic CRPC, Gleason grade 4 at positive surgical margin is predictive of aggressive prostate cancer, Localized prostate cancer: Oral relugolix rapidly achieves castration, More must readsMust reads for theWeek ending May 31, 2020 Prostate cancer: PSMA PET-CT can replace conventional imaging for staging, Is male pattern baldness linked to prostate cancer risk?, Oligometastatic prostate cancer: Stereotactic ablative radiotherapy may slow disease progression, Prostate cancer: Presalvage radiotherapy PSA levels predict bicalutamide response, Prostate cancer: Androgen deprivation therapy tied to risk of iron-deficiency anemia, More must readsMust reads for theWeek ending May 17, 2020 Tomato and lycopene intake may protect against prostate cancer, Testosterone replacement therapy post-radical prostatectomy reduces biochemical recurrence, Cholecystectomy linked to prostate cancer risk in patients with gallstones, Combined biopsy improves detection accuracy in prostate cancer, Prostate cancer: Optimal antiandrogen sequencing in castration-resistant disease, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 last »
